| Page 3 | Cafepharma

You are here

Primary tabs

Linzess Receives Additional Indication in Japan for Chronic Constipation

Post date: August 21, 2018 - 9:38am

FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria

Post date: August 20, 2018 - 9:59am

Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation

Post date: August 20, 2018 - 9:44am

Novo Nordisk Acquires Ground Breaking Glucose Company Ziylo for up to $800M+

Post date: August 17, 2018 - 9:52am

OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon

Post date: August 17, 2018 - 9:24am

BioNTech to Receive $120 Million Upfront Payment from Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza

Post date: August 16, 2018 - 10:11am

Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

Post date: August 16, 2018 - 9:58am

Dose Escalation Cohort to be Initiated in Adaptimmune's MAGE-A4 SPEAR T-Cell Basket Study

Post date: August 15, 2018 - 9:50am

CEL-SCI Gets Independent Recommendation to Continue PH III Head and Neck Cancer Trial

Post date: August 15, 2018 - 9:27am

Onspira Therapeutics' OSP-101 Receives Orphan Drug Designation for Bronchiolitis Obliterans

Post date: August 14, 2018 - 10:31am

Pages